Clinical Trial Update: Brentuximab Vedotin Associated With Chemotherapy in Untreated Patients With Hodgkin Lymphoma. [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating brentuximab vedotin in combination with chemotherapy for untreated Hodgkin lymphoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma

Drugs mentioned

• Brentuximab vedotin (Brentuximab vedotin)

Snippet

Sponsor: The Lymphoma Academic Research Organisation | Conditions: Hodgkin Lymphoma | Phase 2 | Status: COMPLETED